Open AccessLncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway
Author(s) -
Jiandong Li,
Xiuli Xu,
Dandan Zhang,
Li Han,
Xin Gen Lei
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s298679
Subject(s) - competing endogenous rna , gene knockdown , downregulation and upregulation , cisplatin , cancer research , long non coding rna , cell growth , biology , cell culture , cell , gene , chemotherapy , genetics
Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development.